Opinion statement
The quality of life (QOL) of patients requiring urinary diversion remains an important issue within the field of Urology. The majority of this population has undergone cystectomy as treatment for malignant disease. In the initial phases of treatment counseling, the patient is focused on the eradication of their tumor. However, it is the urinary diversion that will have a lasting functional impact on the patient every day for the rest of their lives. The selection of an appropriate diversion, then, is critical to long-term satisfaction with the surgical treatment. Patients must be fully counseled in all types of urinary diversion and should have ready access to all options. Reported differences in QOL between diversion populations are difficult to interpret in view of limitations in the methodology of study designs and apparent selection bias. Ultimately, as a community, urologists cannot definitively say that one class of urinary diversion is superior to another. Instead, we must empower the patient in their own decision making with an accurate impression of diversion recovery, required education and training, and related side-effects and complications. The choice of urinary diversion still remains a very personal decision to be made between the patient, family members, friends, and the physician.
Similar content being viewed by others
References and Recommended Reading
Gerharz EW, Mansson A, Hunt S, Skinner EC, Mansson W: Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol 2005, 174:1729–1736.
Gerharz EW, Mansson A, Mansson W: Quality of life in patients with bladder cancer. Urol Oncol 2005, 23:201–207.
Hobisch A, Tosun K, Kinzl J, et al.: Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. Semin Urol Oncol 2001, 19:18–23.
Porter MP, Wei JT, Penson DF: Quality of life issues in bladder cancer patients following cystectomy and urinary diversion. Urol Clin North Am 2005, 32:207–216.
Wright JL, Porter MP: Quality-of-life assessment in patients with bladder cancer. Nature Clinical Practice Urology. 2007, 4:147–154.
Hautmann RE, Abol-Enein H, et al.: World Health Organization Consensus Conference on Bladder Cancer: Urinary diversion. Urology. 2007, 69:17–49.
Aaronson NK, Ahmedzai S, Bergman B, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365–376.
Cella DF: FACIT Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Evanston, IL: Evanston Northwestern Healthcare and Northwestern University; 1997:
Cella DF, Tulsky DS, Gray G, et al.: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11:570–579.
Cookson MS, Dutta SC, Chang SS, Clark T, Smith JA Jr, Wells N: Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol 2003, 170:1926–1930.
Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, Wei JT: Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer 2007, 109(9):1756–1762
Blanchard CM, Courneya KS, Stein K: Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol 2008, 26:2198–2204.
Karvinen KH, Courneya KS, North S, Venner P: Associations between exercise and quality of life in bladder cancer survivors: a population-based study. Cancer Epidemiol Biomarkers Prev 2007, 16:984–990.
Hardt J, Filipas D, Hohenfellner R, Egle UT: Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study. Qual Life Res 2000, 9:1–12.
Kulaksizoglu H, Toktas G, Kulaksizoglu IB, Aglamis E, Unluer E: When should quality of life be measured after radical cystectomy? Eur Urol 2002, 42:350–355.
Parkinson JP, Konety BR: Health related quality of life assessments for patients with bladder cancer. J Urol 2004, 172:2130–2136.
Allareddy V, Kennedy J, West MM, Konety BR: Quality of life in long-term survivors of bladder cancer. Cancer 2006, 106:2355–2362.
Kikuchi E, Horiguchi Y, Nakashima J, et al.: Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder. Jpn J Clin Oncol 2006, 36:712–716.
Lee CT, Hafez KS, Sheffield JH, Joshi DP, Montie JE: Orthotopic bladder substitution in women: nontraditional applications. J Urol 2004, 171:1585–1588.
Saika T, Arata R, Tsushima T, et al.: Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey. Acta Med Okayama 2007, 61:199–203.
Sogni F, Brausi M, Frea B, et al.: Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology. 2008, 71:919–923.
Weizer AZ, Joshi D, Daignault S, et al.: Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. J Urol 2007, 177:1287–1293.
Mansson A, Al Amin M, Malmstrom P-U, Wijkstrom H, Abol Enein H, Mansson W: Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution–a prospective comparative study. Urology. 2007, 70:1086–1090.
Godin G, Shephard RJ: A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985, 10:141–146.
Hann DM, Jacobsen PB, Azzarello LM, et al.: Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 1998, 7:301–310.
Horn SD, Gassaway J: Practice-based evidence study design for comparative effectiveness research. Med Care 2007, 45:S50–S57.
Lee CT, Latini DM: Urinary diversion: evidence-based outcomes assessment and integration into patient decision-making. BJU International. 2008, 102:1326–1333.
Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473–483.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, C.T. Quality of Life Following Incontinent Cutaneous and Orthotopic Urinary Diversions. Curr. Treat. Options in Oncol. 10, 275–286 (2009). https://doi.org/10.1007/s11864-009-0110-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11864-009-0110-8